Who are the key players in the neuropathic eye pain market?

Some of the key players are Companies, IACTA Pharmaceuticals, Inc., Companies, China, Others.

BUY CHAPTERS

Global Neuropathic Eye Pain Market Research Report 2023

Q: How big is the neuropathic eye pain market?

According to QYResearchs new survey global Neuropathic Eye Pain market is projected to reach US 188.9 million in 2029 increasing from US 152 million in 2022 with the CAGR of 3.1 during the period of 2023 to 2029.

Code: QYRE-Auto-24C14384

Report

June 2023

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

IACTA Pharmaceuticals, Inc.

China

Ocular Therapeutix Inc

Sun Pharmaceutical Industries Ltd.

Novartis

SALVAT

AbbVie

Bausch& Lomb Incorporated

BRIM Biotechnology Inc

Neuropathic Eye Pain Market Size

According to QYResearch’s new survey, global Neuropathic Eye Pain market is projected to reach US$ 188.9 million in 2029, increasing from US$ 152 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029.

Neuropathic Eye Pain Market

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neuropathic Eye Pain market research.

Key companies engaged in the Neuropathic Eye Pain industry include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated and Kala Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Neuropathic Eye Pain were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Neuropathic Eye Pain market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuropathic Eye Pain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Neuropathic Eye Pain Market Report

Report Metric	Details
Report Name	Neuropathic Eye Pain Market
Accounted market size in 2022	US$ 152 million
Forecasted market size in 2029	US$ 188.9 million
CAGR	3.1%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Steroids Antidepressants Anticonvulsants Opioids Others
Segment by Application	Clinic Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, AlconLaboratories, BRIM Biotechnology Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Neuropathic Eye Pain Market market growing?

Ans: The Neuropathic Eye Pain Market market witnessing a CAGR of 3.1% during the forecast period 2023-2029.

What is the Neuropathic Eye Pain Market market size in 2029?

Ans: According to QYResearch’s new survey, global Neuropathic Eye Pain market is projected to reach US$ 188.9 million in 2029, increasing from US$ 152 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuropathic Eye Pain Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Steroids

1.2.3 Antidepressants

1.2.4 Anticonvulsants

1.2.5 Opioids

1.2.6 Others

1.3 Market by Application

1.3.1 Global Neuropathic Eye Pain Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuropathic Eye Pain Market Perspective (2018-2029)

2.2 Neuropathic Eye Pain Growth Trends by Region

2.2.1 Global Neuropathic Eye Pain Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Neuropathic Eye Pain Historic Market Size by Region (2018-2023)

2.2.3 Neuropathic Eye Pain Forecasted Market Size by Region (2024-2029)

2.3 Neuropathic Eye Pain Market Dynamics

2.3.1 Neuropathic Eye Pain Industry Trends

2.3.2 Neuropathic Eye Pain Market Drivers

2.3.3 Neuropathic Eye Pain Market Challenges

2.3.4 Neuropathic Eye Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuropathic Eye Pain Players by Revenue

3.1.1 Global Top Neuropathic Eye Pain Players by Revenue (2018-2023)

3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2018-2023)

3.2 Global Neuropathic Eye Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Neuropathic Eye Pain Revenue

3.4 Global Neuropathic Eye Pain Market Concentration Ratio

3.4.1 Global Neuropathic Eye Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Eye Pain Revenue in 2022

3.5 Neuropathic Eye Pain Key Players Head office and Area Served

3.6 Key Players Neuropathic Eye Pain Product Solution and Service

3.7 Date of Enter into Neuropathic Eye Pain Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Eye Pain Breakdown Data by Type

4.1 Global Neuropathic Eye Pain Historic Market Size by Type (2018-2023)

4.2 Global Neuropathic Eye Pain Forecasted Market Size by Type (2024-2029)

5 Neuropathic Eye Pain Breakdown Data by Application

5.1 Global Neuropathic Eye Pain Historic Market Size by Application (2018-2023)

5.2 Global Neuropathic Eye Pain Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Neuropathic Eye Pain Market Size (2018-2029)

6.2 North America Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Neuropathic Eye Pain Market Size by Country (2018-2023)

6.4 North America Neuropathic Eye Pain Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuropathic Eye Pain Market Size (2018-2029)

7.2 Europe Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Neuropathic Eye Pain Market Size by Country (2018-2023)

7.4 Europe Neuropathic Eye Pain Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuropathic Eye Pain Market Size (2018-2029)

8.2 Asia-Pacific Neuropathic Eye Pain Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2018-2023)

8.4 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuropathic Eye Pain Market Size (2018-2029)

9.2 Latin America Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Neuropathic Eye Pain Market Size by Country (2018-2023)

9.4 Latin America Neuropathic Eye Pain Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuropathic Eye Pain Market Size (2018-2029)

10.2 Middle East & Africa Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2018-2023)

10.4 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 OKYO Pharma

11.1.1 OKYO Pharma Company Detail

11.1.2 OKYO Pharma Business Overview

11.1.3 OKYO Pharma Neuropathic Eye Pain Introduction

11.1.4 OKYO Pharma Revenue in Neuropathic Eye Pain Business (2018-2023)

11.1.5 OKYO Pharma Recent Development

11.2 Ocular Therapeutix, Inc.

11.2.1 Ocular Therapeutix, Inc. Company Detail

11.2.2 Ocular Therapeutix, Inc. Business Overview

11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Introduction

11.2.4 Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023)

11.2.5 Ocular Therapeutix, Inc. Recent Development

11.3 IACTA Pharmaceuticals, Inc.

11.3.1 IACTA Pharmaceuticals, Inc. Company Detail

11.3.2 IACTA Pharmaceuticals, Inc. Business Overview

11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Introduction

11.3.4 IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023)

11.3.5 IACTA Pharmaceuticals, Inc. Recent Development

11.4 Sun Pharmaceutical Industries Ltd

11.4.1 Sun Pharmaceutical Industries Ltd Company Detail

11.4.2 Sun Pharmaceutical Industries Ltd Business Overview

11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Introduction

11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2018-2023)

11.4.5 Sun Pharmaceutical Industries Ltd Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Detail

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Neuropathic Eye Pain Introduction

11.5.4 Novartis AG Revenue in Neuropathic Eye Pain Business (2018-2023)

11.5.5 Novartis AG Recent Development

11.6 SALVAT

11.6.1 SALVAT Company Detail

11.6.2 SALVAT Business Overview

11.6.3 SALVAT Neuropathic Eye Pain Introduction

11.6.4 SALVAT Revenue in Neuropathic Eye Pain Business (2018-2023)

11.6.5 SALVAT Recent Development

11.7 AbbVie Inc

11.7.1 AbbVie Inc Company Detail

11.7.2 AbbVie Inc Business Overview

11.7.3 AbbVie Inc Neuropathic Eye Pain Introduction

11.7.4 AbbVie Inc Revenue in Neuropathic Eye Pain Business (2018-2023)

11.7.5 AbbVie Inc Recent Development

11.8 Bausch &Lomb Incorporated

11.8.1 Bausch &Lomb Incorporated Company Detail

11.8.2 Bausch &Lomb Incorporated Business Overview

11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Introduction

11.8.4 Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2018-2023)

11.8.5 Bausch &Lomb Incorporated Recent Development

11.9 Kala Pharmaceuticals

11.9.1 Kala Pharmaceuticals Company Detail

11.9.2 Kala Pharmaceuticals Business Overview

11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Introduction

11.9.4 Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2018-2023)

11.9.5 Kala Pharmaceuticals Recent Development

11.10 Spectra Vision Care

11.10.1 Spectra Vision Care Company Detail

11.10.2 Spectra Vision Care Business Overview

11.10.3 Spectra Vision Care Neuropathic Eye Pain Introduction

11.10.4 Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2018-2023)

11.10.5 Spectra Vision Care Recent Development

11.11 AlconLaboratories

11.11.1 AlconLaboratories Company Detail

11.11.2 AlconLaboratories Business Overview

11.11.3 AlconLaboratories Neuropathic Eye Pain Introduction

11.11.4 AlconLaboratories Revenue in Neuropathic Eye Pain Business (2018-2023)

11.11.5 AlconLaboratories Recent Development

11.12 BRIM Biotechnology Inc

11.12.1 BRIM Biotechnology Inc Company Detail

11.12.2 BRIM Biotechnology Inc Business Overview

11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Introduction

11.12.4 BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2018-2023)

11.12.5 BRIM Biotechnology Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Companies

IACTA Pharmaceuticals, Inc.

China

Ocular Therapeutix Inc

Sun Pharmaceutical Industries Ltd.

Novartis

SALVAT

AbbVie

Bausch& Lomb Incorporated

BRIM Biotechnology Inc

List of Tables

Table 1. Global Neuropathic Eye Pain Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Steroids

Table 3. Key Players of Antidepressants

Table 4. Key Players of Anticonvulsants

Table 5. Key Players of Opioids

Table 6. Key Players of Others

Table 7. Global Neuropathic Eye Pain Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Neuropathic Eye Pain Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 9. Global Neuropathic Eye Pain Market Size by Region (2018-2023) & (US$ Million)

Table 10. Global Neuropathic Eye Pain Market Share by Region (2018-2023)

Table 11. Global Neuropathic Eye Pain Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 12. Global Neuropathic Eye Pain Market Share by Region (2024-2029)

Table 13. Neuropathic Eye Pain Market Trends

Table 14. Neuropathic Eye Pain Market Drivers

Table 15. Neuropathic Eye Pain Market Challenges

Table 16. Neuropathic Eye Pain Market Restraints

Table 17. Global Neuropathic Eye Pain Revenue by Players (2018-2023) & (US$ Million)

Table 18. Global Neuropathic Eye Pain Market Share by Players (2018-2023)

Table 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2022)

Table 20. Ranking of Global Top Neuropathic Eye Pain Companies by Revenue (US$ Million) in 2022

Table 21. Global 5 Largest Players Market Share by Neuropathic Eye Pain Revenue (CR5 and HHI) & (2018-2023)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Neuropathic Eye Pain Product Solution and Service

Table 24. Date of Enter into Neuropathic Eye Pain Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neuropathic Eye Pain Market Size by Type (2018-2023) & (US$ Million)

Table 27. Global Neuropathic Eye Pain Revenue Market Share by Type (2018-2023)

Table 28. Global Neuropathic Eye Pain Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 29. Global Neuropathic Eye Pain Revenue Market Share by Type (2024-2029)

Table 30. Global Neuropathic Eye Pain Market Size by Application (2018-2023) & (US$ Million)

Table 31. Global Neuropathic Eye Pain Revenue Market Share by Application (2018-2023)

Table 32. Global Neuropathic Eye Pain Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 33. Global Neuropathic Eye Pain Revenue Market Share by Application (2024-2029)

Table 34. North America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. North America Neuropathic Eye Pain Market Size by Country (2018-2023) & (US$ Million)

Table 36. North America Neuropathic Eye Pain Market Size by Country (2024-2029) & (US$ Million)

Table 37. Europe Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. Europe Neuropathic Eye Pain Market Size by Country (2018-2023) & (US$ Million)

Table 39. Europe Neuropathic Eye Pain Market Size by Country (2024-2029) & (US$ Million)

Table 40. Asia-Pacific Neuropathic Eye Pain Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 41. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2018-2023) & (US$ Million)

Table 42. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2024-2029) & (US$ Million)

Table 43. Latin America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Latin America Neuropathic Eye Pain Market Size by Country (2018-2023) & (US$ Million)

Table 45. Latin America Neuropathic Eye Pain Market Size by Country (2024-2029) & (US$ Million)

Table 46. Middle East & Africa Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 47. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2018-2023) & (US$ Million)

Table 48. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2024-2029) & (US$ Million)

Table 49. OKYO Pharma Company Detail

Table 50. OKYO Pharma Business Overview

Table 51. OKYO Pharma Neuropathic Eye Pain Product

Table 52. OKYO Pharma Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 53. OKYO Pharma Recent Development

Table 54. Ocular Therapeutix, Inc. Company Detail

Table 55. Ocular Therapeutix, Inc. Business Overview

Table 56. Ocular Therapeutix, Inc. Neuropathic Eye Pain Product

Table 57. Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 58. Ocular Therapeutix, Inc. Recent Development

Table 59. IACTA Pharmaceuticals, Inc. Company Detail

Table 60. IACTA Pharmaceuticals, Inc. Business Overview

Table 61. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product

Table 62. IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 63. IACTA Pharmaceuticals, Inc. Recent Development

Table 64. Sun Pharmaceutical Industries Ltd Company Detail

Table 65. Sun Pharmaceutical Industries Ltd Business Overview

Table 66. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product

Table 67. Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 68. Sun Pharmaceutical Industries Ltd Recent Development

Table 69. Novartis AG Company Detail

Table 70. Novartis AG Business Overview

Table 71. Novartis AG Neuropathic Eye Pain Product

Table 72. Novartis AG Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 73. Novartis AG Recent Development

Table 74. SALVAT Company Detail

Table 75. SALVAT Business Overview

Table 76. SALVAT Neuropathic Eye Pain Product

Table 77. SALVAT Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 78. SALVAT Recent Development

Table 79. AbbVie Inc Company Detail

Table 80. AbbVie Inc Business Overview

Table 81. AbbVie Inc Neuropathic Eye Pain Product

Table 82. AbbVie Inc Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 83. AbbVie Inc Recent Development

Table 84. Bausch &Lomb Incorporated Company Detail

Table 85. Bausch &Lomb Incorporated Business Overview

Table 86. Bausch &Lomb Incorporated Neuropathic Eye Pain Product

Table 87. Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 88. Bausch &Lomb Incorporated Recent Development

Table 89. Kala Pharmaceuticals Company Detail

Table 90. Kala Pharmaceuticals Business Overview

Table 91. Kala Pharmaceuticals Neuropathic Eye Pain Product

Table 92. Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 93. Kala Pharmaceuticals Recent Development

Table 94. Spectra Vision Care Company Detail

Table 95. Spectra Vision Care Business Overview

Table 96. Spectra Vision Care Neuropathic Eye Pain Product

Table 97. Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 98. Spectra Vision Care Recent Development

Table 99. AlconLaboratories Company Detail

Table 100. AlconLaboratories Business Overview

Table 101. AlconLaboratories Neuropathic Eye Pain Product

Table 102. AlconLaboratories Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 103. AlconLaboratories Recent Development

Table 104. BRIM Biotechnology Inc Company Detail

Table 105. BRIM Biotechnology Inc Business Overview

Table 106. BRIM Biotechnology Inc Neuropathic Eye Pain Product

Table 107. BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2018-2023) & (US$ Million)

Table 108. BRIM Biotechnology Inc Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Neuropathic Eye Pain Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Neuropathic Eye Pain Market Share by Type: 2022 VS 2029

Figure 3. Steroids Features

Figure 4. Antidepressants Features

Figure 5. Anticonvulsants Features

Figure 6. Opioids Features

Figure 7. Others Features

Figure 8. Global Neuropathic Eye Pain Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 9. Global Neuropathic Eye Pain Market Share by Application: 2022 VS 2029

Figure 10. Clinic Case Studies

Figure 11. Hospital Case Studies

Figure 12. Others Case Studies

Figure 13. Neuropathic Eye Pain Report Years Considered

Figure 14. Global Neuropathic Eye Pain Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 15. Global Neuropathic Eye Pain Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Neuropathic Eye Pain Market Share by Region: 2022 VS 2029

Figure 17. Global Neuropathic Eye Pain Market Share by Players in 2022

Figure 18. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2022)

Figure 19. The Top 10 and 5 Players Market Share by Neuropathic Eye Pain Revenue in 2022

Figure 20. North America Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. North America Neuropathic Eye Pain Market Share by Country (2018-2029)

Figure 22. United States Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Neuropathic Eye Pain Market Share by Country (2018-2029)

Figure 26. Germany Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. France Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. U.K. Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Italy Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Russia Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Nordic Countries Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Asia-Pacific Neuropathic Eye Pain Market Share by Region (2018-2029)

Figure 34. China Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Japan Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. South Korea Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Southeast Asia Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. India Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Australia Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Latin America Neuropathic Eye Pain Market Share by Country (2018-2029)

Figure 42. Mexico Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Brazil Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Middle East & Africa Neuropathic Eye Pain Market Share by Country (2018-2029)

Figure 46. Turkey Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Saudi Arabia Neuropathic Eye Pain Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. OKYO Pharma Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 49. Ocular Therapeutix, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 50. IACTA Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 51. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 52. Novartis AG Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 53. SALVAT Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 54. AbbVie Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 55. Bausch &Lomb Incorporated Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 56. Kala Pharmaceuticals Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 57. Spectra Vision Care Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 58. AlconLaboratories Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 59. BRIM Biotechnology Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2018-2023)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Neuropathic Eye Pain Market Research Report 2023

Published Date: June 2023

Report Code: QYRE-Auto-24C14384

Global Neuropathic Eye Pain Market Research Report 2023

FEATURED COMPANIES

Neuropathic Eye Pain Market Size

Neuropathic Eye Pain Market

Report Scope

Scope of Neuropathic Eye Pain Market Report

FAQ for this report

How fast is Neuropathic Eye Pain Market market growing?

What is the Neuropathic Eye Pain Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS